Liraglutide and semaglutide reduce MACE in diabetes patients regardless of PAD status: Study Medha Baranwal21 April 2022 9:00 AM ISTDenmark: Liraglutide and semaglutide may reduce major adverse cardiovascular events (MACE) in type 2 diabetes (T2D) patients regardless of their...
Novo Nordisk bags CDSCO Panel nod to study Semaglutide Roshni Dhar9 April 2022 10:29 AM ISTIn line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 8/April/2022 Roshni Dhar8 April 2022 5:36 PM ISTHere are the top health stories for the day:NMC launches online monitoring system for PG medical admissions, directs colleges to submit info With...
NovoNordisk gets CDSCO panel okay to study anti-diabetic drug Semaglutide Dr. Divya Colin5 April 2022 5:56 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the...
Semaglutide an effective alternative drug option to treat obesity MD Editorial Team24 Feb 2022 9:00 AM ISTObesity is a seriously neglected disease that is factually a multifactorial chronic disease affecting 650 million adults globally. It is associated...
Semaglutide to be efficient in weight loss in obese Patients Dr. Nandita Mohan7 Feb 2022 6:18 PM ISTObesity is a serious concern not only known to risk heart health but several other metabolic diseases are connected to obesity. Among adults with...
Novo Nordisk India unveils oral Semaglutide to treat diabetes Roshni Dhar25 Jan 2022 5:53 PM ISTDrug firm Novo Nordisk India on Thursday said it has launched a first of its kind diabetes treatment medication in the country. The company said it...
Health Bulletin 25/January/2022 Roshni Dhar25 Jan 2022 5:49 PM ISTHere are Top Health stories of the day India reports 2.55 lakh daily new Covid-19 cases, lowest in a weekNEET counselling 2021 registrations: MCC...
First: Novo Nordisk India launches oral Semaglutide for diabetes treatment Ruchika Sharma24 Jan 2022 10:00 AM ISTNew Delhi: Drug firm Novo Nordisk India on Thursday said it has launched a first of its kind diabetes treatment medication in the country. The company...
Type 2 diabetes: Semaglutide better than dulaglutide for reducing blood sugar and body weight, study finds Medha Baranwal12 Jan 2022 10:15 AM ISTDenmark: In an indirect treatment comparison (ITC), semaglutide 2.0 mg showed significantly greater reductions in blood sugar levels and body weight...
Semaglutide once weekly can help weight loss in obese individuals Dr. Nandita Mohan19 Oct 2021 3:15 PM ISTOnce-weekly semaglutide (2.4 mg) in adjunct with diet and exercise, is effective for weight loss in non-diabetic obese or overweight adults, finds a...
Medical Bulletin 13/October/2021 Dr. Nandita Mohan13 Oct 2021 7:00 PM ISTHere are the top Medical stories of the dayReused transplanted liverDexamethasone may help cancer patients survive longerAnkle fracture patients at...
